Pathological self-aggregation of β(2)-microglobulin: a challenge for protein biophysics

Gennaro Esposito1, Alessandra Corazza, Vittorio Bellotti

  • 1Dipartimento di Scienze Mediche e Biologiche, Università di Udine, P.le Kolbe, 4, 33100, Udine, Italy, rino.esposito@uniud.it.

Sub-Cellular Biochemistry
|December 11, 2012
PubMed

Insights

Pathological aggregation of beta-2 microglobulin (b2m) involves complex mechanisms. An alternative collagen-dependent pathway is proposed, differing from prion-like conversion models.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Pathology

Background:

  • Beta-2 microglobulin (b2m) aggregation is linked to pathological conditions.
  • The precise mechanism driving systemic b2m fibril deposition remains unclear.
  • Existing hypotheses lack conclusive evidence.

Purpose of the Study:

  • To critically review current hypotheses on b2m aggregation mechanisms.
  • To explore alternative pathways for b2m fibril formation.
  • To investigate the role of protein structure and environment in aggregation.

Main Methods:

  • Review of existing mechanistic hypotheses.
  • Analysis of structural and morphological data from electron microscopy, atomic force microscopy, and solid-state NMR.
  • Critical evaluation of prion-like conversion models.

Main Results:

  • Direct characterization methods provide structural insights but not mechanistic clarity.
  • Prion-like conversion models face challenges aligning with established fibrillogenesis conditions.
  • An alternative mechanism involving full-length b2m near collagen is proposed.

Conclusions:

  • The collagen-dependent mechanism offers a plausible alternative to rare-event-driven aggregation.
  • This pathway may explain physiological b2m deposition.
  • Further research is needed to validate this collagen-mediated mechanism.